TY  - GEN
AU  - Fox,Elizabeth
AU  - Aplenc,Richard
AU  - Bagatell,Rochelle
AU  - Chuk,Meredith K
AU  - Dombi,Eva
AU  - Goodspeed,Wendy
AU  - Goodwin,Anne
AU  - Kromplewski,Marie
AU  - Jayaprakash,Nalini
AU  - Marotti,Marcelo
AU  - Brown,Kathryn H
AU  - Wenrich,Barbara
AU  - Adamson,Peter C
AU  - Widemann,Brigitte C
AU  - Balis,Frank M
TI  - A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors
SN  - 1527-7755
PY  - 2011///0120
KW  - Administration, Oral
KW  - Adolescent
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Area Under Curve
KW  - Child
KW  - Female
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Neoplasms
KW  - drug therapy
KW  - Quinazolines
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2010.30.9674
ER  -